Olema Oncology, the Bay Area biotech run by former AstraZeneca executive Sean Bohen, raised $180 million from a private placement and a credit facility of up to $50 million from Silicon Valley Bank to advance its breast cancer treatment.
The biotech announced Tuesday that it can receive $25 million once…
Click here to view original post
